These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 10489508)

  • 1. The role of endovaginal ultrasonography and the value of endometrial biopsy in breast cancer patients on tamoxifen therapy.
    Sivalingam N; Pathmalingam A
    Singapore Med J; 1999 Jun; 40(6):402-4. PubMed ID: 10489508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different coexisting endometrial histological features in asymptomatic postmenopausal breast cancer patients treated with tamoxifen.
    Cohen I; Altaras MM; Shapira J; Tepper R; Cordoba M; Figer A; Zalel Y; Dror Y; Beyth Y
    Gynecol Obstet Invest; 1997; 43(1):60-3. PubMed ID: 9015703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tamoxifen and endometrial pathology].
    Negoiţă M; Terinte C; Mihailovici MS
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):1114-7. PubMed ID: 21500468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of the progesterone test in screening for endometrial pathology in asymptomatic postmenopausal women receiving treatment with tamoxifen.
    Lubian López DM; Fernandez YG; Rodríguez BR; López FM; Delgado RC
    Menopause; 2010; 17(3):487-93. PubMed ID: 20464783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indication for histological examination of endometrium in breast carcinoma patients receiving tamoxifen therapy.
    Ito T; Katagiri C; Murata Y; Hamazoe R; Morita K
    J Obstet Gynaecol Res; 2001 Jun; 27(3):141-5. PubMed ID: 11561830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective endometrial assessment of breast cancer patients treated with third generation aromatase inhibitors.
    Garuti G; Cellani F; Centinaio G; Montanari G; Nalli G; Luerti M
    Gynecol Oncol; 2006 Nov; 103(2):599-603. PubMed ID: 16750259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of endovaginal ultrasonography in assessing tamoxifen-associated changes of the endometrium. A prospective study.
    Strauss HG; Wolters M; Methfessel G; Buchmann J; Koelbl H
    Acta Obstet Gynecol Scand; 2000 Aug; 79(8):697-701. PubMed ID: 10949237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes mimicking endometrial neoplasia in postmenopausal, tamoxifen-treated women with breast cancer: a transvaginal Doppler study.
    Achiron R; Lipitz S; Sivan E; Goldenberg M; Horovitz A; Frenkel Y; Mashiach S
    Ultrasound Obstet Gynecol; 1995 Aug; 6(2):116-20. PubMed ID: 8535913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endometrial thickness in tamoxifen-treated patients: correlation with clinical and pathologic findings.
    Hann LE; Giess CS; Bach AM; Tao Y; Baum HJ; Barakat RR
    AJR Am J Roentgenol; 1997 Mar; 168(3):657-61. PubMed ID: 9057510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of transvaginal ultrasonography in the endometrial evaluation of breast cancer patients using tamoxifen.
    Kazerooni T; Ghaffarpasand F; Mosalaei A; Kazerooni Y
    Med Princ Pract; 2010; 19(3):222-7. PubMed ID: 20357508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrial evaluation in postmenopausal breast cancer patients receiving tamoxifen: an ultrasound, color flow Doppler, hysteroscopic and histological study.
    Exacoustos C; Zupi E; Cangi B; Chiaretti M; Arduini D; Romanini C
    Ultrasound Obstet Gynecol; 1995 Dec; 6(6):435-42. PubMed ID: 8903921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The endometrium in asymptomatic breast cancer patients on tamoxifen: value of transvaginal ultrasonography with saline infusion and Doppler flow.
    Develioğlu OH; Omak M; Bilgin T; Esmer A; Tüfekçi M
    Gynecol Oncol; 2004 May; 93(2):328-35. PubMed ID: 15099941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A simple inexpensive screening test for endometrial abnormalities in asymptomatic women using tamoxifen.
    Archer DF
    Menopause; 2010; 17(3):454-5. PubMed ID: 20386342
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevalence of endometrial proliferation in pipelle biopsies in tamoxifen-treated postmenopausal women with breast cancer in Kuwait.
    Al-Azemi M; Labib NS; Motawy MM; Temmim L; Moussa MA; Omu AE
    Med Princ Pract; 2004; 13(1):30-4. PubMed ID: 14657616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disaccordance between estimation of endometrial thickness as measured by transvaginal ultrasound compared with hysteroscopy and directed biopsy in breast cancer patients treated with tamoxifen.
    Liedman R; Lindahl B; Andolf E; Willen R; Ingvar C; Ranstam J
    Anticancer Res; 2000; 20(6C):4889-91. PubMed ID: 11205237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elastosonographic evaluation of endometrium in women using tamoxifen for breast cancer.
    Gultekin IB; Imamoglu GI; Gultekin S; Yilmaz EA; Yilmaz Z; Alkan A; Kucukozkan T
    Niger J Clin Pract; 2019 Jan; 22(1):92-100. PubMed ID: 30666026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ATAC ('Arimidex', Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: baseline endometrial sub-protocol data on the effectiveness of transvaginal ultrasonography and diagnostic hysteroscopy.
    Duffy S; Jackson TL; Lansdown M; Philips K; Wells M; Pollard S; Clack G; Coibion M; Bianco AR;
    Hum Reprod; 2005 Jan; 20(1):294-301. PubMed ID: 15513977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasonography of the endometrium and endometrial pathology under tamoxifen treatment.
    Friedrich M; Villena-Heinsen C; Mink D; Endres V; Reitnauer K; Schmidt W
    Eur J Gynaecol Oncol; 1998; 19(6):536-40. PubMed ID: 10215436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective longitudinal study of ultrasound screening for endometrial abnormalities in women with breast cancer receiving tamoxifen.
    Fung MF; Reid A; Faught W; Le T; Chenier C; Verma S; Brydon E; Fung KF
    Gynecol Oncol; 2003 Oct; 91(1):154-9. PubMed ID: 14529676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamoxifen use and endometrial lesions: hysteroscopic, histological, and immunohistochemical findings in postmenopausal women with breast cancer.
    Dibi RP; Zettler CG; Pessini SA; Ayub AV; de Almeida SB; da Silveira GP
    Menopause; 2009; 16(2):293-300. PubMed ID: 19034048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.